http://rdf.ncbi.nlm.nih.gov/pubchem/reference/7886070

Outgoing Links

Predicate Object
contentType Clinical Trial|Clinical Trial, Phase II|Journal Article
endingPage 1849
issn 1532-1827
0007-0920
issueIdentifier 10
pageRange 1846-1849
publicationName British Journal of Cancer
startingPage 1846
bibliographicCitation Veronese ML, Sun W, Giantonio B, Berlin J, Shults J, Davis L, Haller DG, O'Dwyer PJ. A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer. British Journal of Cancer. 2005 May 03;92(10):1846–9. doi: 10.1038/sj.bjc.6602569.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55601451500ba84e36266da617b1bba9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b9f601e3be568d994e1a706e3b1b6c55
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_320ac8c67be504184140db5d6bd334f1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_83edea69396ba9839f658e79348ea003
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ac3e0764bb3d3566e965c0dc20e795f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_33b96df704f9b1d942b0d5eaaf134e0b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_891a9faa58f42552cc786719a32b40d4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_484b59bddf055fba481fd0353ec6b688
date 2005-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC2361767
https://pubmed.ncbi.nlm.nih.gov/15870719
https://doi.org/10.1038/sj.bjc.6602569
isPartOf https://portal.issn.org/resource/ISSN/0007-0920
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/1532-1827
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title A phase II trial of gefitinib with 5-fluorouracil, leucovorin, and irinotecan in patients with colorectal cancer
discusses http://id.nlm.nih.gov/mesh/M0018336
http://id.nlm.nih.gov/mesh/M0004519
http://id.nlm.nih.gov/mesh/M0147530
http://id.nlm.nih.gov/mesh/M0008631
http://id.nlm.nih.gov/mesh/M0444984
http://id.nlm.nih.gov/mesh/M0003242
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135436482
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403648
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3385
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7507
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11445

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127394900
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129683629
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129520161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127394890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127925204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128740937
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127377427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129555111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136058681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129430288

Total number of triples: 62.